// App-Quantinova.ai

93 2016 RESS : Antiarrhythmic Drugs for Shock Refractory Secondary Ventricular Fibrillation Following Initial Nonshockable Out-of-Hospital Cardiac Arrest: The Resuscitation Outcomes Consortium Amiodarone, Lidocaine or Placebo Study

Researchers

Presenter

  • Mohamud Daya

Principal Investigators

  • Joe P Ornato

  • Myron L Weisfeldt

  • Ian G Stiell

  • Ahamed G Idris

  • Tom P Aufderheide

  • James V Dunford

  • M Riccardo Colella

  • Gary M Vilke

  • Ashley M Brienza

  • Patrice Desvigne-Nickens

  • Tom Rea

  • Pamela Gray

  • Randal Gray

  • Norman Seals

  • Ron Strait

  • Paul Dorian

  • Graham Nichol

  • Laurie J Morrison

  • Christian Vaillancourt

  • Lynn Wittwer

  • Clifton W Callaway

  • James Christenson

  • Debra Egan

Medical Centers

  • Natl Heart Lung and Blood Inst, Washington, DC

  • University of California-San Diego, San Diego, CA

  • The University of Texas Southwestern, Dallas, TX

  • Clark County Emergency Medical Services, Vancouver, WA

  • University of Washington, Seattle, WA

  • Dallas Fire-Rescue, Dallas, TX

  • Oregon Health and Science University, Portland, OR

  • The Medical College of Wisconsin, Milwaukee, WI

  • Virginia Commonwealth University, Mineral, VA

  • Univ of Ottawa, Ottawa, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • University of Alabama, Birmingham, AL

  • British Columbia Emergency Medical Services, Vancouver, BC, Canada

  • U Toronto, Toronto, ON, Canada

  • Johns Hopkins University, Baltimore, MD

  • University of Pittsburgh, Pittsburgh, PA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

  • Cardiac arrest

Biomarkers

  • N/A

Drug/Treatment

  • Amiodarone Hydrochloride

  • Lidocaine

  • ADL-8-7223

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved